Cited by 20Regulation of Appetite and ObesityEating Disorders and BehaviorsPharmacology and Obesity Treatment

Food Intake in Prader‐Willi Syndrome and Controls with Obesity After Administration of a Benzodiazepine Receptor Agonist

Open access
Fieldstone, Annette, Zipf, William B., Sarter, Martin F., Berntson, Gary G.·1998·Obesity Research

Abstract

Benzodiazepine receptor (BZR) agonists, used extensively for their anxiolytic effects, have been shown to increase food intake in many mammalian species. Little information, however, is available on the effects of BZR agonists on feeding behaviors of humans. Food intake was evaluated in a 60‐minute free‐feeding standardized test after the acute administration of the BZR agonist chlordiazepoxide (CDP, Librium; 5 mg or 20 mg) or placebo. Subjects were 12 individuals with the Prader Willi syndrome (PWS), a disorder characterized by extreme hyperphagia and morbid obesity, and 11 controls with obesity. PWS subjects showed the characteristic hyperphagia associated with the appetite disorder, consuming more than six times as many sandwiches as controls with obesity. Results revealed no significant effect of either dose of CDP on the food intake of either group. Serum assays revealed that dose‐dependent, clinically effective levels of CDP and active metabolites were achieved. These results suggest that acute administration of the BZR agonist CDP, at the therapeutic levels used, may not increase food intake in populations with obesity. However, the chronic effects of CDP on appetite in human populations still need to be explored.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/j.1550-8528.1998.tb00311.x

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Soubrie P, eds. Animal Models of Psychiatric Disorders (3). Switzerland: Basel, Switzerland: S . Karger: 199 I ; 2 U .
  2. Cooper SJ, Yerbury RE. Midazolam-induced hyperphagia and FG7 142-induced anorexia: Behavioral characteristics in the rat. Pharmacol Biochem Behav. 1986;25:99-106.
  3. Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, eds. Goodman & Gilmun's The Pharmucological Basis of Therapeutics. 9th ed. New York: McGraw-Hill; I996;424.
  4. Yerbury RE, Cooper SJ. The benzodiazepine partial ago- nists, Ro 16-6028 and Ro 17-18 12, increase palatable food con- sumption in nondeprived rats. Pharmacol Biochem Behav. I987;28:427-43 1.

Cited by

Sorted by citations

Authors
Fieldstone, A., Zipf, W. B., Sarter, M. F., & Berntson, G. G.
Affiliations
The Ohio State University (US)
Corresponding author
Zipf, William B.
Venue
Obesity Research
Publisher
Wiley
Published
1998-01
Volume
6
Issue
1
Pages
29-33
ISSN
  • 1071-7323 (ISSN-L)
  • 1550-8528
OpenAlex
W2093016228
Cited by
20
References
26
Citations by year
2025: 1 · 2023: 1 · 2022: 1 · 2020: 1 · 2017: 1 · 2016: 1 · 2015: 2 · 2013: 1 · 2012: 2
FWCI
0.12
Type
journal article
Language
en
Open access
Locations
  • Obesity Research (publishedVersion)
  • PubMed (publishedVersion)
Funders
Ohio State University
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Social Sciences › Psychology › Clinical Psychology › Eating Disorders and Behaviors
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
Keywords
Prader-Willi syndrome, hyperphagia, dietary intake, chlordiazepoxide, benzodiazepine receptor agonists, obesity, appetite, drug metabolism
MeSH terms
Adolescent, Adult, Child, Chlordiazepoxide, Eating, Female, Humans, Male, Obesity, Prader-Willi Syndrome, GABA-A Receptor Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review